230 related articles for article (PubMed ID: 27122094)
1. The enhancing effect of a laser photochemotherapy with cisplatin or zolendronic acid in primary human osteoblasts and osteosarcoma cells in vitro.
Heymann PG; Ziebart T; Kämmerer PW; Mandic R; Saydali A; Braun A; Neff A; Draenert GF
J Oral Pathol Med; 2016 Nov; 45(10):803-809. PubMed ID: 27122094
[TBL] [Abstract][Full Text] [Related]
2. Laser-enhanced cytotoxicity of zoledronic acid and cisplatin on primary human fibroblasts and head and neck squamous cell carcinoma cell line UM-SCC-3.
Heymann PG; Mandic R; Kämmerer PW; Kretschmer F; Saydali A; Neff A; Draenert FG
J Craniomaxillofac Surg; 2014 Oct; 42(7):1469-74. PubMed ID: 24947610
[TBL] [Abstract][Full Text] [Related]
3. Effect of low level laser therapy and zoledronate on the viability and ALP activity of Saos-2 cells.
Bayram H; Kenar H; Taşar F; Hasırcı V
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):140-6. PubMed ID: 22571861
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Tumor Cell Metabolism by Laser Photochemotherapy with Cisplatin or Zoledronic Acid
Heymann PGB; Henkenius KSE; Ziebart T; Braun A; Hirthammer K; Halling F; Neff A; Mandic R
Anticancer Res; 2018 Mar; 38(3):1291-1301. PubMed ID: 29491052
[TBL] [Abstract][Full Text] [Related]
5. The effects of laser irradiation on osteoblast and osteosarcoma cell proliferation and differentiation in vitro.
Renno AC; McDonnell PA; Parizotto NA; Laakso EL
Photomed Laser Surg; 2007 Aug; 25(4):275-80. PubMed ID: 17803384
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of bisphosphonate and radiation on osteosarcoma cells.
Ryu K; Murata H; Koto K; Horie N; Matsui T; Nishigaki Y; Sakabe T; Takeshita H; Itoi M; Kimura S; Ashihara E; Maekawa T; Fushiki S; Kubo T
Anticancer Res; 2010 Jul; 30(7):2713-20. PubMed ID: 20683003
[TBL] [Abstract][Full Text] [Related]
7. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.
Tsai SR; Yin R; Huang YY; Sheu BC; Lee SC; Hamblin MR
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):123-30. PubMed ID: 25462575
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
[TBL] [Abstract][Full Text] [Related]
9. Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid.
Basso FG; Turrioni AP; Soares DG; Bagnato VS; Hebling J; de Souza Costa CA
Support Care Cancer; 2014 Oct; 22(10):2741-8. PubMed ID: 24801347
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of zoledronic acid against human osteosarcoma cells.
Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W
J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic and inflammatory effects of alendronate and zolendronate on human osteoblasts, gingival fibroblasts and osteosarcoma cells.
Açil Y; Arndt ML; Gülses A; Wieker H; Naujokat H; Ayna M; Wiltfang J
J Craniomaxillofac Surg; 2018 Apr; 46(4):538-546. PubMed ID: 29454604
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.
Benassi MS; Chiechi A; Ponticelli F; Pazzaglia L; Gamberi G; Zanella L; Manara MC; Perego P; Ferrari S; Picci P
Cancer Lett; 2007 Jun; 250(2):194-205. PubMed ID: 17113707
[TBL] [Abstract][Full Text] [Related]
13. An in vitro and in vivo study of combination therapy with Photogem®-mediated photodynamic therapy and cisplatin on mouse cancer cells (CT-26).
Ge R; Ahn JC; Shin JI; Bahk CW; He P; Chung PS
Photomed Laser Surg; 2011 Mar; 29(3):155-60. PubMed ID: 21054201
[TBL] [Abstract][Full Text] [Related]
14. Phototoxic effect of na-pheophorbide a toward osteosarcoma cells in vitro using a laser diode.
Nagai Y; Aizawa S; Iriuchishima T; Goto B; Nagaoka M; Tokuhashi Y; Saito A
Photomed Laser Surg; 2014 Sep; 32(9):481-9. PubMed ID: 25105597
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation.
Quattrini I; Conti A; Pazzaglia L; Novello C; Ferrari S; Picci P; Benassi MS
Oncol Rep; 2014 Jan; 31(1):370-5. PubMed ID: 24253938
[TBL] [Abstract][Full Text] [Related]
16. The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
Morgan C; Lewis PD; Jones RM; Bertelli G; Thomas GA; Leonard RC
Acta Oncol; 2007; 46(5):669-77. PubMed ID: 17562444
[TBL] [Abstract][Full Text] [Related]
17. Methylene blue mediated photobiomodulation on human osteoblast cells.
Ateş GB; Ak A; Garipcan B; Gülsoy M
Lasers Med Sci; 2017 Nov; 32(8):1847-1855. PubMed ID: 28776111
[TBL] [Abstract][Full Text] [Related]
18. Low concentrations of alendronate increase the local invasive potential of osteoblastic sarcoma cell lines via connexin 43 activation.
Yoshitani K; Kido A; Honoki K; Akahane M; Fujii H; Tanaka Y
Pathol Res Pract; 2011 Jul; 207(7):417-22. PubMed ID: 21665377
[TBL] [Abstract][Full Text] [Related]
19. Determination of Optimum Operation Parameters for Low-Intensity Pulsed Ultrasound and Low-Level Laser Based Treatment to Induce Proliferation of Osteoblast and Fibroblast Cells.
Coskun ME; Coskun KA; Tutar Y
Photomed Laser Surg; 2018 May; 36(5):246-252. PubMed ID: 29466082
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma.
Wu W; Li W; Zhou Y; Zhang C
Int J Clin Exp Pathol; 2014; 7(10):7114-22. PubMed ID: 25400807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
